Can Losartan (angiotensin II receptor antagonist) cause hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Losartan Cause Hyponatremia?

Yes, losartan can cause hyponatremia, though it is a rare adverse effect compared to other medications. This has been documented in case reports, with severe cases requiring medical intervention 1.

Evidence for Losartan-Induced Hyponatremia

Case Reports and Clinical Evidence

  • A case report documented severe hyponatremia (serum sodium 123 mEq/L) in a 73-year-old diabetic patient after 3.5 months of losartan 50 mg daily therapy 1
  • Another study reported 40 cases of hyponatremia associated with losartan/hydrochlorothiazide combination (Preminent®), with an average lowest sodium value of 114.4 mEq/L 2
    • In this study, symptoms developed either progressively (within 50 days) or after precipitating factors like fever or appetite loss (after 50 days)
    • Recovery typically occurred within 6.8 days after discontinuation

Mechanism and Risk Factors

Losartan, as an angiotensin II receptor blocker (ARB), may cause hyponatremia through:

  • Interference with the renin-angiotensin-aldosterone system
  • Potential enhancement of antidiuretic hormone (ADH) effects
  • Altered renal sodium handling

Risk factors that may increase susceptibility include:

  • Advanced age (most reported cases were in elderly patients)
  • Concomitant use of other medications that can cause hyponatremia
  • Underlying renal dysfunction
  • Volume depletion states

Clinical Management Considerations

Monitoring

For patients on losartan therapy:

  • Monitor serum electrolytes, particularly in high-risk patients (elderly, those with renal impairment)
  • Be vigilant for symptoms of hyponatremia: confusion, drowsiness, weakness, headache
  • Consider more frequent monitoring during the first few months of therapy

Treatment of Losartan-Induced Hyponatremia

If hyponatremia develops:

  1. Assess severity of symptoms and sodium level
  2. Consider discontinuation of losartan (de-challenge)
  3. Provide appropriate sodium correction based on acuity and severity
  4. Avoid overly rapid correction to prevent central pontine myelinolysis

Alternative Medications

If hyponatremia occurs with losartan, consider alternative antihypertensive medications:

  • Calcium channel blockers (amlodipine, felodipine) may be suitable alternatives in patients with hypertension 3
  • ACE inhibitors may not be appropriate alternatives as they share similar mechanisms and potential for hyponatremia

Special Populations and Considerations

Elderly Patients

Elderly patients appear to be at higher risk for losartan-induced hyponatremia:

  • The mean age in the case series of 40 patients was 76.4 years 2
  • Careful monitoring of electrolytes is particularly important in this population

Patients with Heart Failure

For patients with heart failure:

  • Hyponatremia is a potential concern with ARB therapy
  • The European Society of Cardiology notes that ARBs should be used with caution in certain populations 3
  • Monitoring for electrolyte disturbances is recommended when using ARBs in heart failure patients

Conclusion

While hyponatremia is not among the most common adverse effects of losartan, case reports indicate it can occur, particularly in elderly patients. Clinicians should be aware of this potential adverse effect and monitor patients accordingly, especially those with risk factors for developing electrolyte disturbances.

References

Research

A case of losartan-induced severe hyponatremia.

Journal of pharmacology & pharmacotherapeutics, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.